SRPT
NASDAQ · Biotechnology
Sarepta Therapeutics Inc
$17.53
+0.57 (+3.36%)
Open$17.05
Previous Close$16.96
Day High$18.01
Day Low$17.05
52W High$25.32
52W Low$10.42
Volume—
Avg Volume2.96M
Market Cap1.85B
P/E Ratio28.45
EPS$0.07
SectorBiotechnology
Analyst Ratings
Hold
33 analysts
Price Target
+127.0% upside
Current
$17.53
$17.53
Target
$39.80
$39.80
$34.71
$39.80 avg
$61.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.35B | 1.77B | 549.72M |
| Net Income | -762,284,836 | -515,560,496 | -107,586,925 |
| Profit Margin | -32.5% | -30.8% | -19.6% |
| EBITDA | -726,906,604 | -518,945,873 | -125,300,242 |
| Free Cash Flow | — | — | -79,607,758 |
| Rev Growth | +33.1% | +33.1% | +15.5% |
| Debt/Equity | 0.73 | 0.73 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |